| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |